Evidence method
Level · gp.fundamentals.debt_to_revenue
30.48% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Sep 30, 2022
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-22-000054General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.41% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
24.59% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-2.77% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
60.14% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
39.02% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
27.11% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.98% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.87% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 32.67%
- Current
- 30.48%
- Delta
- -2.19%
- Previous
- 8.57%
- Current
- 8.41%
- Delta
- -0.16%
- Previous
- 22.44%
- Current
- 24.59%
- Delta
- 2.15%
- Previous
- 6.59%
- Current
- -2.77%
- Delta
- -9.37%
- Previous
- 53.36%
- Current
- 60.14%
- Delta
- 6.78%
- Previous
- 41.68%
- Current
- 39.02%
- Delta
- -2.67%
- Previous
- 29.61%
- Current
- 27.11%
- Delta
- -2.51%
- Previous
- 1.87%
- Current
- 1.98%
- Delta
- 0.11%
- Previous
- 0.71%
- Current
- 0.87%
- Delta
- 0.16%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_DECREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.